LEF1/TCFs are high mobility group box-containing transcriptional factors mediating canonical Wnt/β-catenin signaling during early embryogenesis and tumorigenesis. β-Catenin forms a complex with LEF1/TCFs and transactivates LEF1/TCF-mediated transcriptions during dorsalization. Although LEF-mediated transcription is also implicated in ventralization, the underlying molecular mechanism is not well understood. Using the vertebrate Xenopus laevis model system, we found that Xom, which is a ventralizing homeobox protein with dual roles of transcriptional activation and repression, forms a complex with LEF1/TCF through its homeodomain and transactivates LEF1/TCF-mediated transcription through its N-terminal transactivation domain (TAD). Our data show that Xom lacking the N-terminal TAD fails to transactivate ventral genes, such as BMP4 and Xom itself, but retains the ability to suppress transcriptional activation of dorsal gene promoters, such as the Goosecoid promoter, indicating that transactivation and repression are separable functions of Xom. It has been postulated that Xom forms a positive re-enforcement loop with BMP4 to promote ventralization and to suppress dorsal gene expression. Consistent with an essential role of Xom transactivation of LEF1/TCFs during early embryogenesis, we found that expression of the dominant-negative Xom mutant that lacks the TAD fails to re-enforce the ventral signaling of BMP4 and causes a catastrophic effect during gastrulation. Our data suggest that the functional interaction of Xom and LEF1/TCF-factors is essential for ventral cell fate determination and that LEF1/TCF factors may function as a point of convergence to mediate the combined signaling of Wnt/β-catenin and BMP4/Xom pathways during early embryogenesis.
Introduction
Xom (also called Vent2, Vox and Xbr-1), a cell fate determination factor of the Vent family of homeobox genes, is both a transcriptional repressor and an activator [1] [2] [3] [4] . During early embryogenesis, Xom is implicated in the formation of ventral mesoderm and in defining the dorsoventral patterning [5, 6] . Zygotic Xom transcription starts after midblastula transition (MBT) and distributes from a more ubiquitous expression pattern during the early gastrula stage to the ventral-lateral regions as gastrulation proceeds [1, 3] . The expression of Xom appears to be positively regulated by signals from the ventral signal center, such as BMP4, but negatively regulated by dorsal-specific genes, such as Goosecoid (Gsc) and noggin [1, 2] . Xom expression in turn contributes to the formation of the dorsoventral pattern by promoting the expression of ventral genes such as BMP4 and the Vent genes, and by inhibiting the expression of dorsal-organizer genes such as Gsc and chordin [2, 3, 7] . To exert its transcriptional repressor function, Xom binds directly to the distal element in promoters of dorsal specific genes (such as the Gsc promoter), and inhibits their Cell Research | www.cell-research.com Functional interaction of Xom and LEF1/TCFs 346 npg transcription [8] . The molecular mechanism underlying the transcriptional activation function of Xom, however, remains to be fully defined.
The LEF1/TCFs are a family of high mobility group (HMG) transcriptional factors that possess no intrinsic transcriptional activities. Rather, the LEF1/TCF-mediated transcription activities are tightly controlled by their associated factors [9] . In a non-induction state, the LEF1/ TCFs are associated with transcriptional repressors, such as Grouch and CtBP, which maintain the LEF1/TCF-mediated transcription in a repressed state [10] [11] [12] [13] [14] . During early embryogenesis, local enrichment of β-catenin in the future dorsal side of embryos allows it to interact with LEF1/TCFs and to induce the expression of dorsal-specific genes, such as Siamois, Twin and Xnr [15] [16] [17] [18] . Besides determination of cell fate during early embryogenesis, excessive activation of LEF1/TCF-mediated transcription by β-catenin has also been implicated as the initial step of malignant transformation in a variety of cancers [19] . Since LEF1/TCFs represent the transcriptional action point of Wnt/β-catenin signaling, LEF1/TCF-responsive luciferase reporter activity has generally been utilized as an indicator of Wnt/β-catenin activities.
The role of LEF1/TCFs in ventral cell fate determination is less clear, although several studies have implicated their potential involvement. For example, expression profiling showed that members of LEF1/TCF family are broadly distributed in ventral-posterior regions [20, 21] . Mutagenesis studies revealed that LEF1-/-TCF-/-mice carry caudal defects with neural expansion [22] and that loss of function of LEF1 leads to ventral rather than dorsal defects in Xenopus [23] . Consistent with the possible involvement of LEF1/TCFs in ventral cell fate determination, promoter analysis revealed that many ventral genes, such as Xom and Bambi, contain LEF1/TCF binding sites [24] . Mutations of the LEF1/TCF binding sites in these ventral genes cause significant inhibition of their responsiveness to BMP4 signaling [24] .
To further define the role of LEF1/TCF factors in ventral cell fate determination, we examined the potential effect of Xom on LEF1/TCF-mediated transcription. We found that Xom forms a complex with LEF1/TCF factors and transactivates LEF1/TCF-mediated transcription. To explore the molecular mechanism of Xom transactivation of LEF1/TCF-mediated transcription, we found that similar to the case of LEF1/TCF transactivation by β-catenin [25] , the domains of Xom involved in LEF1/TCF interaction and transactivation are different. We have located the TAD of Xom to its N-terminal region, which is separated from the transcriptional repressor domain of Xom. We have further defined that the C-terminal region of LEF1 is involved in interaction with Xom. We found that the Xom TAD is required for transactivation of ventral specific genes, such as BMP4 and Xom itself. Expression of a dominant-negative Xom that lacks the TAD inhibits BMP4 signaling and disrupts embryogenesis at the gastrulation stage. Our data suggest that the functional interaction between Xom and LEF1/TCF factors plays an essential role in ventral cell fate determination during early embryogenesis. We therefore propose a model in which the LEF1/TCF transcription factors, previously known to be the transcriptional action point of Wnt/β-catenin signaling, may serve as a point of convergence to mediate the combined signaling effect of BMP/Xom and Wnt/β-catenin pathways during dorsalventral patterning.
Materials and Methods

Preparation of Xenopus embryos, microinjection and luciferase assays
Protocols for handling embryos and for luciferase assays were essentially as described previously [26] . For a typical cellular luciferase assay, 2×10 5 cells were split into 12-well cell-culture plates, incubated for 24 h and then transfected with 3 µl of liposome transfection reagent (TransIT1, Mirus), using 1 µg of DNA plasmids of selected genes and 0.3 µg of reporter plasmids (HeLa cells require one-third while 293T cells require one-sixth of the DNA and liposome amount). At 48 h post-transfection, cells were washed with PBS, lysed with 1× cell lysis buffer (Promega cell lysis buffer), scraped and collected. After incubation on ice for 30 min, cells were cleared by centrifugation at 12 000×g for 15 s, and supernatants were transferred to a new tube; then 20 ml of the cell lysate was mixed with 100 µl of Luciferase Assay reagent (Promega), and the luciferase activity was measured by a TR717 Microplate luminometer (Applied Biosystem).
Plasmids and recombinant proteins
Xenopus LEF1, LEF1DHMG, LEF1DN60, LEF1DN160, Xom, and Xom deletion mutants were subcloned by the polymerase chain reaction based technique into the pCS2+ and PGEX4T3 vectors, and the constructs were verified by in vitro translation and sequencing. pGL3-OT and pGL3-OF were generous gifts from Dr B Volgestein; p2.4BMP4-Luc was a generous gift from Dr J Feng; pGL3 promoter MSX2 (WT) and pGL3 promoter MSX2-SDM-600/-766 were generous gifts from Dr C Sirard.
Preparation of nuclear and cytoplasmic extracts
Cells (4×10 6 ) were trypsinized and washed twice with PBS and pelleted by centrifugation. Total protein was obtained by lysing the cells in 150 µl of RIPA buffer (150 mM NaCl, 1% NP40, 0.5% DOC, 0.1% SDS, 50 mM Tris pH 8.0) containing 1× proteinase inhibitors (Roche, proteinase inhibitor cocktail). Cytoplasmic proteins were obtained by incubation of 2×10 6 cells with 150 µl of hypotonic buffer (0.05% NP40, 10 mM HEPES pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 1 mM DTT) containing 1× proteinase inhibitors on ice for 10 min followed by centrifugation at 4 000 r.p.m. for 2 min. The supernatants were collected and used as cytoplasmic protein fractions. The nuclear pellets were washed twice with PBS. Nuclear proteins were obtained by incubating the pellet on ice for 60 min in 150 µl of RIPA buffer. Levels of β-catenin in fractioned cellular extracts were determined Hong Gao et al. 347
npg by western blotting using a specific antibody (Takara Bio).
GST pull-down assay
Five micrograms of GST fusion proteins and 5 µl of 35 S-labeled proteins derived from in vitro translation were mixed with 20 µl of 50% glutathione Sepharose 4B beads in 500 µl of binding buffer (50 mM Tris pH 8.0, 100 mM NaCl, 50 mM KCl, 5 mM MgCl 2 , 1 mM DTT, 10% glycerol and 0.2% NP40). The mixtures were incubated at 4 ºC for 3 h and washed with 1× PBS plus 0.2% NP40 four times. Bound material was released with 2× sample buffer, boiled at 95 ºC for 5 min, centrifuged briefly, and revealed by SDS-PAGE and autoradiography.
Co-immunoprecipitation
The affinity protein G beads were prepared by mixing 20 µl of protein G plus-Agarose beads (Santa Cruz Biotechnology) with 1 µg of corresponding antibody. A total of 2×10 6 of cells were lysed with 1× cell lysis buffer (Promega) containing 1× protease inhibitor reagent (Roche), incubated on ice for 30 min, sonicated briefly and centrifuged at 12 000×g for 5 min at 4 ºC. The supernatants were further cleaned with 20 µl of untreated protein G plus-Agarose beads and 2 µg of pre-immune serum for 2 h at 4 ºC. The supernatants were then mixed with 20 µl of prelabeled protein G plus-Agarose beads at 4 ºC overnight. The beads were washed four times with PBS plus 0.2% NP40. Bound proteins were released by 2× sample buffer, boiled at 95 ºC for 5 min, centrifuged briefly and revealed by western blot analysis with specific antibodies.
Histological staining
Embryos were fixed with 3.7% formaldehyde, 0.1 M MOPS (pH 7.4), 2 mM EGTA, and 1 mM MgSO 2 at indicated stages. The embryos were then embedded in paraffin and sectioned at a 10 mm thickness. The sections were stained with hematoxylin and eosin (H&E), and subjected to histological analysis. The sections were further stained with 2 µg/ml of 4',6-diamidino-2-phenylindole, dihydrochloride (DAPI) (Invitrogen) to reveal the nuclei of embryonic cells.
Analysis of gene expression by real-time PCR
Total RNA was extracted by Trisol methods. Eight embryos from each treatment group were pooled and homogenized in 1 ml of Trizol (Invitrogen). Chloroform (200 µl) was then added to the sample. After vortex mixing, the samples were centrifuged at 12 000 r.p.m. for 1 min and the supernatants were collected in new tubes. Isoproponol (500 µl) was added to each sample, mixed and kept at RT for 10 min. Samples were then centrifuged for 30 min. The pellets were washed twice with 70% ethanol, air dried and suspended in 100 µl of ddH 2 O. The final RNA concentration was determined by measurement at OD 260 . First-strand cDNA was synthesized with the SuperScript first-strand synthesis system (Invitrogen) according to the manufacturer's protocol. Briefly, 2.5 µg of total RNA from each sample was used. The final volume of the RT product was 20 ml and was diluted to 200 µl (10× dilution); 8 µl of the diluted RT product was used for real-time PCR using LightCycler System (Roche) and LightCycler FastStart DNA Master SYBR Green I, according to the manufacturer's instructions. The relative levels of gene expression were calculated by the formula relative gene expression=2 -DCd (DCd = cycle of the specific gene-cycle of the reference Histone-4 gene). Each sample was carried out in triplicate. The sequences of the primers are available upon request. 
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Results
Xom transactivates LEF1/TCF-mediated transcription
Xom is a major ventral cell fate determination factor of the BMP4 signaling pathway. Using the TOPflash assay, a previous investigation has located LEF1/TCF-mediated transcriptional activities in the ventral-posterior side of embryos [27] . By injecting TOPflash plasmid into the two ventral blastomeres at the four-cell stage and examining luciferase activities during gastrulation stage, we have also confirmed the LEF1/TCF-mediated transcriptional activities on the ventral side of embryos during early embryogenesis (data not shown, the pGL3-OT, which contains three copies of the optimal TCF binding motif, was a generous gift from Dr B Vogelstein) [28] . To explore a potential inter-relationship between Xom expression and LEF/TCF-mediated transcription, we examined the effect of Xom expression on LEF1/TCF-mediated transcription using the TOPflash-luciferase assay. When mRNA encoding Xom was co-injected with the TOPflash reporter construct into Xenopus embryos at the two-cell stage, expression of Xom enhanced the TOPflash reporter transcription by sevenfold as compared with embryos injected with a construct of TOPflash alone ( Figure 1A ). The trans-activating effect of Xom on the TOPflash reporter was specific, since expression of Xom did not activate the control FOPflash reporter ( Figure 1A ) (pGL3-OF, also a gift from Dr Vogelstein), which contains mutations at the LEF/TCF binding sites [28] . To determine whether Xom transactivation of LEF1/TCF-mediated transcription is dependent on cellular contexts of embryos, we also studied the effect of Xom expression on LEF1/TCF-mediated transcription in non-embryonic cells. When plasmids for Xom and TOPflash were co-transfected into HeLa and HCT116 
Xom binds to LEF1/TCF factors in vivo and in vitro
Binding of LEF1/TCFs to the promoter of TOPflash is required for the activation of the reporter construct; thus, the finding that expression of Xom activates TOPflash but not FOPflash raised the possibility that Xom activates the TOPflash reporter through interaction with LEF/TCFs. We tested this hypothesis by determining whether Xom physically interacts with LEF1/TCFs. We carried out co-immunoprecipitation experiments in HCT116 cells transiently transfected with myc-Xom. We found that immunoprecipitation of endogenous TCF4 with anti-TCF4 antibodies co-precipitated the Xom protein (Figure 2A and 2B) . The in vivo association between Xom and TCF4 appears to be strong and could not be dissociated with 300 mM NaCl and 0.1% NP40. Our previous investigations showed that Xom is an unstable protein and that Xom Ser140/144 to alanine mutation renders the Xom mutant (Xs) resistant to ubiquitin-mediated proteolysis [26] . To determine whether Ser140/144 to alanine mutation interferes with the interaction between Xom and LEF1/TCF-factors, we have also included myc-tagged Xs in the co-immunoprecipitation experiments. Our results showed that myc-Xs binds to TCF4 as efficiently as the wild-type Xom ( Figure  2B ), indicating that the Ser140/144 to alanine mutation does not interfere with the interaction between Xom and LEF1/TCF-factors. To determine the domain of Xom that mediates its interaction with LEF1/TCFs, we made serial deletion mutants of Xom and tested their interactions with TCF4 in vivo (Figure 2A and 2C ). All Xom mutants that carry the homeobox region co-immuno-precipitated with anti-TCF4 beads, while those that lack the homeodomain did not. These data indicate that the homeodomain of Xom plays a critical role in mediating complex formation between Xom and LEF1/TCF factors. Given that the homeobox domain is the DNA-binding domain of Xom, to rule out the possibility that the observed interaction between Xom and TCF4 is mediated indirectly by nucleic acids, we included ethidium bromide (EtB, at 20 mg/ml) in the pull-down assays [29] . We found that EtB did not interrupt the interaction between TCF4 and Xom or Xom mutants that carry the homeodomain, indicating that the interaction between Xom and TCF4 is not dependent on their potential association with DNA (data not shown). Following the demonstration of complex formation between Xom and TCF4 in vivo, we went further to identify the critical domains of LEF1/TCFs involved in the interaction with Xom. At least four members of the LEF1/TCF family have been identified in vertebrates (LEF1, TCF1, TCF3 and TCF4), and LEF1 shows an expression pattern similar to that of Xom. Zygotic transcription of LEF1 starts after the onset of the MBT and is enriched at the ventral-caudal side of the animal [20] . Genetic data indicate that LEF1 is essential for ventral-posterior patterning [23] , consistent with the notion that LEF1 might be a potential candidate as the Xom-interacting protein. We therefore tested whether Xom interacts with LEF1 and explored the critical domain of LEF1 involved in the interaction through deletion analysis ( Figure 2D and 2E ). During our pilot cotransfection studies, we found that very few cells co-expressed Xom and full-length LEF1 (data not shown); therefore, we probed the potential interaction between Xom and LEF1 through an in vitro binding assay. When in vitro translation products of 35 S-labeled LEF1 or its deletion mutants were mixed with GST-Xom or GST alone, LEF1 was pulled down by GST-Xom but not by the control GST ( Figure 2E ). The C-terminal-deleted mutant LEF1DHMG appeared to have much less affinity for Xom, whereas the N-terminal-deleted mutants, LEF1DN60 and LEF1DN160, bound to GST-Xom as effectively as did the wild-type LEF1 ( Figure 2E ). Thus, the interaction between Xom and LEF1 appears to be dependent on the LEF1 C-terminal motif, a supposition further supported by a LEF1/TCF transactivation assay ( Figure  3D ). To determine the potential physiological relevance of Xom transactivation of LEF1/TCF-mediated transcription, we examined the effect of Xom on the expression of BMP4 downstream genes, using promoter-luciferase analysis. The Msx2 gene is downstream of BMP4, and its promoter contains both an LEF1/TCF binding site and a BMP4-responsive element (SBE) [30] . Consistent with the potential direct involvement of LEF1/TCFs in BMP/Xom signaling, we found that Xom activates both the wild-type Msx2 promoter and the SBE-mutated Msx2 promoter that retains only the functional LEF1/TCF binding site (data not shown).
Xom transactivation of LEF1/TCF-mediated transcription is not mediated through β-catenin accumulation
Previous studies have shown that LEF1/TCF-mediated transcription is activated by β-catenin [31] [32] [33] . To explore the mechanism of Xom activation of LEF1/TCF-mediated transcription and to rule out the possibility that Xom transactivation of LEF1/TCF-mediated transcription is through an increase in β-catenin protein level or nuclear translocation, we examined the effect of Xom expression on the protein level and intracellular distribution of β-catenin in HCT116 cells. As shown in Figure 3A -C, whereas Xom expression activates LEF1/TCF-mediated transcription in a concentration-dependent manner ( Figure 3A) , there is no corresponding increase (rather, a small decrease was observed) in the level of total intracellular β-catenin protein ( Figure 3B ). In addition, when the total intracellular proteins were fractionated into the cytoplasmic and nuclear portions, no significant increase of nuclear β-catenin was observed upon Xom expression (rather, a small decrease was observed) ( Figure 3C ). As shown in Figure 2 , the domain of LEF1 that interacts with Xom locates at the C-terminal region of LEF1, which is separated from the N-terminal domain involved in interaction with β-catenin. Consistent with the notion that Xom transactivates LEF1/ TCF-mediated transcription through their direct interaction, we found that LEF1DN60, a dominant-negative LEF1 mutant that is known to block β-catenin transactivation of LEF1/TCF-mediated transcription but retains the ability to interact with Xom, promotes Xom transactivation of the LEF1/TCF-responsive reporter in the TOPflash assay (Figure 3D) . In comparison, the LEF1D HMG mutant, which fails to interact with Xom, reduces Xom transactivation of the LEF1/TCF-responsive reporter ( Figure 3D ).
Xom transactivates LEF1/TCFs through its N-terminal TAD
The interaction between Xom and LEF1 allowed us to further explore the molecular mechanism underlying Xom transactivation of LEF1/TCF-mediated transcription. Previous studies have shown that β-catenin binds to TCFs through its central Armadillo repeats and activates TCFs through its C-terminal motif [25, 34] . Therefore, after identifying the critical domain of Xom involved in LEF1/TCF interaction, we further analyzed the functional domain of Xom involved in activating LEF1/TCF-mediated transcription. When cDNA encoding Xom or its deletion mutants was co-transfected with the reporter construct of TOPflash into 293T cells, expression of both Xom and its Cterminal deletion mutant XomCD85 activated the TOPflash reporter by almost 10-fold comparing with control cells transfected with TOPflash only ( Figure 5A ). In contrast, the ability to activate the LEF1/TCF-responsive reporter proposed that Xom forms a positive re-enforcement loop with BMP4 to promote ventral cell fate [3] . To determine whether the Xom N-terminal TAD plays a role in Xom transactivation of ventral specific genes, we examined the effect of XomND175 on transactivation of the BMP4 promoter during early embryogenesis (the BMP4-luciferase construct was a generous gift of Dr J Feng [35, 36] ). We found that, in contrast to Xom, XomND175 failed to transactivate the BMP4 promoter ( Figure 4D ). Moreover, in comparison with the luciferase activities in control embryos, embryos injected with XomND175 revealed less luciferase activities, suggesting that expression of XomND175 exerts a dominant-negative effect to block the promotion of BMP4 expression by endogenous Xom. To further determine the effect of Xom TAD on the expression of genes downstream of BMP4 signaling, each of mRNA encoding Xom or its deletion mutants were mixed with mRNA encoding Activin, and then co-injected with the Gsc-promoter-luciferase construct into the embryos at the two-cell stage. We found that both the N-terminal deletion and the C-terminal deletion mutants of Xom strongly inhibited Activin-induced activation of the Gsc promoter ( Figure 4B ). These data indicate that the function of Xom TAD is independent of the Xom repressor function, and that the Xom TAD resides in its N-terminal region, a notion that was further supported by TOPflash assays in early embryos ( Figure 4C ).
Xom N-terminal TAD is requried for ventral signaling
Xom is emerging as an essential cell fate determination factor during mesoderm differentiation to promote the expression of ventral specific genes [6] . It has been Figure 4E ). In contrast, expression of XomND175 failed to enhance the expression of BMP4, suggesting that the Xom TAD is required for its transactivation of BMP4 expression. Moreover, consistent with the disruption of the positive auto feedback loop of BMP4 and Xom, expression of XomND175 exerted a strong inhibitory effect on the expression of Xom itself ( Figure 4F ). Together with the notion that LEF1/TCF binding sites in the promoters of ventral specific genes are required for their responsiveness to BMP4 signaling and that loss of function of LEF1 leads to ventral defects [23, 24] , our findings suggest that Xom transactivation of LEF1/TCF-mediated transcription is likely to play a critical role in ventral signaling and ventral cell fate determination.
Xom transactivation of LEF1/TCFs is essential for gastrulation
Our biochemical and mutagenesis studies revealed that Xom possesses a LEF1/TCF-TAD in its N-terminal region. We have identified a Xom mutant, XomND175, which possesses negligible ability to transactivate LEF1/TCF but retains the transcriptional repressor function. To determine the potential physiological function of Xom transactivation of LEF1/TCF-mediated transcription during early embryogenesis, we used the loss-of-function approach and explored the effect of XomND175 expression on embryogenesis. We obtained mRNAs encoding Xom, XomND175, and other Xom deletion mutants through in vitro transcription. The mRNAs were diluted to desired concentration with distilled water and injected into one of the two ventral blastomeres at the four-cell stage as indicated ( Figure  5A ). We observed that embryos injected with mRNA of XomND175, but not other Xom mutants, showed catastrophic effects during gastrulation ( Figure 5A) . Moreover, the effects of XomND175 appeared to be stage-specific. Unlike XomND175 mRNA, XomND175 cDNA caused little, if any, abnormalities during gastrulation ( Figure 5A ). Closer inspection showed that the embryos injected with XomND175 mRNA progressed through the cleavage and pregastrulation stages; however, as gastrulation begins, many large whitish gray-colored cells appear in the injected side ( Figure 5B ). As gastrulation proceeds, these cells gradually lose a defined cellular appearance, giving the embryos a "rotten" appearance. To define the cellular and histological changes associated with XomND175 expression, we fixed the XomND175-mRNA-injected and control embryos, sliced them into 10-µM thin sections, and stained them with H&E and DAPI. Little histological change was associated with ND175 expression at the cleavage and pregastrulation stages, but many large rounded-up structures were seen at the gastrulation stage, which appeared to be dead cells. None of these large rounded-up structures in ND175-injected embryos stained with DAPI, suggesting that they had lost normal cellular structures, such as the nucleus ( Figure 5C, arrow head) . The embryos appeared to be very sensitive to the effect of XomND175. The 50% effective penetration rate was achieved with less than 50 pg of XomND175 mRNA (data not shown). The finding that expression of a dominant-negative Xom mutant that lacks TAD led to embryonic arrest at the gastrulation stage suggests that Xom transactivation of LEF1/TCF-mediated transcription is essential for gastrulation. Similar findings have been noted for other transcriptional factors related to BMP4 signaling, such as Bix3 [37] .
Discussion
LEF1/TCFs are essential cell fate determination factors whose transcriptional activities are directed by associated factors. Previous studies have described the role of β-catenin as the transcriptional activator of LEF1/TCFs and the essential functions of β-catenin activated LEF1/ TCF-mediated transcription in dorsoventral patterning, ontogenesis and malignant transformation. Our current investigation indicates that Xom, a homeobox transcription factor with dual roles of transcriptional repressor and activator functions, activates LEF1/TCF-mediated transcription. We found that Xom forms a complex with LEF1/TCF factors and activates LEF1/TCF-mediated transcription through its N-terminal TAD. Our finding that a dominant-negative Xom mutant that lacks the TAD leads to embryonic development arrest at the gastrulation stage suggests that Xom transactivation of LEF1/TCF-mediated transcription is essential for cell fate determination during early embryogenesis.
LEF1/TCFs are architectural transcription factors that may induce sharp bending in the DNA helix [31, 38, 39] . Multiple transcriptional factors were found to modulate the β-catenin/LEF1/TCF signaling [40] [41] [42] . The findings that Xom, a transcription factor that offsets the β-catenin effects on cell fate, binds to LEF1/TCF factors and transactivates LEF1/TCF-mediated transcription through its N-terminal TAD, therefore, presents a new paradigm to understand LEF1/TCF-mediated transactivation and its consequence in cell fate determination. Distinguished from β-catenin, npg Xom functions also as a transcriptional repressor. Thus, the finding that Xom transactivates LEF1/TCF-mediated transcription reveals a potential mechanism to account for the dual transcriptional functions of Xom. We have mapped the Xom TAD to the N-terminal region of Xom. We have yet to determine whether Xom TAD interacts with the basic transcriptional machinery directly or acts through other intermediates. Previous investigations have shown that Smads binds to both LEF1/TCFs and Xom/Vent-2 [30, [42] [43] [44] . Thus, possibilities exist that Smads may modulate Xom transactivation of LEF1/TCF target genes, similar to their involvement in β-catenin transactivation of LEF1/TCFmediated transcription [30, 42, 44] . Further investigations would help to decipher how multiple signaling pathways are integrated in cell fate determination.
Xom and BMP4 have been postulated to form a positive re-enforcement loop to promote ventral cell fate and to inhibit dorsal cell fate. Previous studies have shown that Xom and BMP4 promote the expression of each other and enhance the expression of ventral genes, such as the BMP4, Wnt8, Vent1 and Xom itself [2, 3] . The molecular mechanism of Xom transactivation of ventral genes was not clear. Recent mutagenesis analysis of ventral gene promoters revealed the critical role of the LEF1/TCF binding sites of these promoters in their responsiveness to BMP4 signaling [24] . Thus, our findings that Xom binds to LEF1/TCF factors and transactivates LEF1/TCF-mediated transcription suggest a mechanistic explanation for Xom-mediated activation of ventral gene expression. The potential involvement of Xom transactivation of LEF1/TCF-mediated transcription in vivo is consistent with the findings of Ramel and Lekven, [45] who showed that depletion of Xom-like molecules (such as Vent and Vox) by morpholino reduces TOP activities in some embryos. The essential role of Xom transactivation of LEF1/TCF-mediated transcription during early embryogenesis was implicated by the catastrophic effect of expressing the dominant-negative Xom that lacks the TAD (XomND175). XomND175 therefore may serve as a useful probe to explore the essential genes and signaling pathways underlying Xom induced cell fate determination during early embryogenesis.
The molecular mechanism underlying the establishment of dorsoventral asymmetry from the symmetrical fertilized eggs constitutes a fundamental question that is of broad interest in both the biology of early development as well as pathogenesis of a variety of diseases, such as neogenesis and degeneration. The results of previous investigations revealed the critical role of dorsal and ventral organizers in the establishment of dorsoventral asymmetry. Previous investigations have defined the role of LEF1/TCFs as a component of Wnt/β-catenin signaling pathway during the establishment of dorsal organizing center. Our current investigations present several lines of evidence indicating that LEF1/TCFs also participate in the BMP4/Xom signaling of the ventral signal center ( Figure 5D, upper panel) . The LEF1/TCFs, a prior known component of the Wnt/β-catenin pathway, therefore, may function as the point of convergence to integrate the combined signaling effects of the Wnt/β-catenin and BMP4/Xom pathways during the establishment of the dorsal-ventral axis ( Figure 5D , lower panel). Both β-catenin and Xom are activators of LEF1/ TCF-mediated transcription; therefore, β-catenin and Xom could potentially function in a synergistic or antagonizing fashion in a context-dependent manner. The complexity of the promoters of BMP and Wnt downstream genes and the availability of other participating co-factors may play a critical role in the readout of the combined signaling effects of these two pathways. It has been found that the Wnt and BMP pathways synergize to promote the expression of ventral posterior genes, such as Tbx6, but counteract to regulate the expression of dorsal genes, such as geminin [46, 47] . Extensive investigations have identified multiple extracellular molecules as the mediator of the cross-talk between the dorsal and ventral signaling; our identification of the LEF1/TCF factors as the convergence point of the dorsal and ventral signaling pathway, therefore, presents a new paradigm in understanding the intracellular integration of the dorsal and ventral signaling in cell fate determination during early embryogenesis.
